You searched for COVID-19 - Page 8 of 35

Global IVD Companies Report Second Quarter 2024 Earnings

IN THE SECOND QUARTER OF 2024, in vitro diagnostics (IVD) companies reported solid revenues as well as new tests, analyzers, and automation. Most of the IVD companies boosted diagnostic sales in low single digit amounts. During the earnings calls, financial analysts asked company leaders about growth they may see in 2025. Overall, with the decline […]

To access this post, you must purchase The Dark Report.

Global IVD Companies Report Second Quarter 2024 Earnings Read More »

Identifying Current Lab Trends from Labcorp and Quest Experience

TDR Insider / Robert Michel

Many different factors influence the operations of clinical laboratories in the United States today. One good source of competitive business intelligence is for lab administrators to follow the quarterly earnings calls of the nation’s two biggest public lab corporations. With coast-to-coast operations, they are often first to experience and respond to new trends—whether its more

To access this post, you must purchase The Dark Report.

Identifying Current Lab Trends from Labcorp and Quest Experience Read More »

Identifying Current Lab Trends from Labcorp & Quest Experience

Laboratory Management / Robert Michel

CEO SUMMARY: Many different factors influence the operations of clinical laboratories in the United States today. One good source of competitive business intelligence is for lab administrators to follow the quarterly earnings calls of the nation’s two biggest public lab corporations. With coast-to-coast operations, they are often first to experience and respond to new trends—whether

To access this post, you must purchase The Dark Report.

Identifying Current Lab Trends from Labcorp & Quest Experience Read More »

2023 Ranking of the World’s Top 13 IVD Corporations

In Vitro Diagnostics / Robert Michel

BASED ON 2023 DIAGNOSTICS-RELATED REVENUE, four in vitro diagnostics (IVD) manufacturers continued to lead the global IVD market just as they did in 2022. They are: Thermo Fisher Scientific, Inc., Roche Holdings, Abbott Laboratories, and Danaher Corporation. The top 13 firms collected $88.7 billion in annual revenue, compared to $99 billion in fiscal 2022 and

To access this post, you must purchase The Dark Report.

2023 Ranking of the World’s Top 13 IVD Corporations Read More »

Global IVD Companies Report First Quarter 2024 Earnings

In Vitro Diagnostics / Robert Michel

IN THEIR INITIAL FINANCIAL REPORTING FOR 2024, in vitro diagnostics (IVD) company leaders shared priorities and progress in the first quarter (Ql) while also acknowledging heightened competition in diagnostics. And, for some of the IVD manufacturers, a need for new leaders and perspective is being addressed. Here is a summary of recent financials, key accomplishments,

To access this post, you must purchase The Dark Report.

Global IVD Companies Report First Quarter 2024 Earnings Read More »

June 10, 2024, Intelligence: Late-Breaking Lab News

Late Breaking Lab News / Robert Michel

Once a high-flier lab test manufacturer with a market valuation of $2 billion, Cue Health of San Diego filed for Chapter 7 bankruptcy on May 28. Analysts now say the company is valued at about $15 million. Founded in 2010, Cue Health was developing a test system that consumers could use at home. Its components

To access this post, you must purchase The Dark Report.

June 10, 2024, Intelligence: Late-Breaking Lab News Read More »

Labcorp, Quest Issue Q1 Earnings, Offer Comments on FDA’s LDT Rule

Lab Marketplace / Robert Michel

BOTH LABCORP, BURLINGTON, N.C., AND QUEST DIAGNOSTICS, SECAUCUS, N.J., reported strong financial performance during the first quarter (Q1) of 2024. Base business—diagnostics excluding COVID-19 testing—jumped about 6% during Q1 as compared to base business in Q1 2023. Here is an overview of their financial results as well as key Q1 accomplishments. LABCORP: Grows Q1

To access this post, you must purchase The Dark Report.

Labcorp, Quest Issue Q1 Earnings, Offer Comments on FDA’s LDT Rule Read More »

Labcorp, Quest Diagnostics Discuss Q4 & 2023 Earnings

Clinical Laboratory / Robert Michel

DURING RECENT EARNINGS CALLS WITH FINANCIAL ANALYSTS AND INVESTORS, both Labcorp and Quest Diagnostics discussed their fourth quarter (Q4) and full year 2023 financial results. Each reported some stability in the market for clinical laboratory testing services, reflected in the numbers reported for test volume and pricing. Quest Diagnostics’ earnings call was first, on Feb.

To access this post, you must purchase The Dark Report.

Labcorp, Quest Diagnostics Discuss Q4 & 2023 Earnings Read More »

Labs Should Prepare for Arrival of ‘Perfect Storm’

Clinical Laboratory Trends / Robert Michel

CEO SUMMARY: In the near future, clinical labs and pathology groups will need to address three major developments. One involves the FDA proposed LDT rule. A second is the adoption by payers of guidelines that require genetic test claims to have Z-Codes. The third centers around coming reforms and updates to the 1992 CLIA rules.

To access this post, you must purchase The Dark Report.

Labs Should Prepare for Arrival of ‘Perfect Storm’ Read More »

Is There Evidence That Some Doctors Wish to Use Local Labs?

Managed Care Contracts / Virchow

EDITOR’S NOTE: Our column, Virchow, is written by anonymous insiders working within the managed care world. The column aims to help clients of The Dark Report better understand the decisions, policies, and actions of payers as they manage their laboratory networks, establish coverage guidelines, process lab test claims, and audit labs. CONVENTIONAL WISDOM HOLDS THAT

To access this post, you must purchase The Dark Report.

Is There Evidence That Some Doctors Wish to Use Local Labs? Read More »

Search Results for: COVID-19